Skip to main content
. 2020 Oct 17;12(10):3023. doi: 10.3390/cancers12103023

Figure 2.

Figure 2

NRF2 directs numerous metabolic processes that impact cancer cell survival and proliferation, including NADPH production and the metabolism of lipids, amino acids, nucleotides, and iron/heme (a). These NRF2-regulated metabolic pathways are outlined in (b). NRF2 directs the transcription of numerous genes that encode for metabolic enzymes and transporters, including those involved in the pentose phosphate pathway (G6PD, PGD, TALDO1, TKT), nucleotide biosynthesis (PPAT, MTHFD2), serine/ glycine biosynthesis (PHGDH, PSAT1, SHMT1/2), heme/iron metabolism (FECH, HMOX1, BLVRB1), glutathione synthesis and utilization (TXN, TXNRD1, GSH, GSR, GCLC, GCLM, GPX4), amino acid metabolism (GLS, ASNS, SLC7A11/xCT), NADPH production (ME1, IDH1), and lipid biosynthesis (FAS). Abbreviations: Substrates: G6P, glucose-6-phosphate; R5P, ribose-5-phosphate; PRPP, phosphoribosyl pyrophosphate; IMP, inosine monophosphate; F6P, fructose-6-phosphate; GA3P, glyceraldehyde-3-phosphate; 3PG, 3-phosphoglycerate; 3-PHP, 3-phospho-hydroxypyruvate; 3-PS, 3-phosphoserine; 10-Formyl-THF, 10-formyltetrahydrofolate; CO, carbon monoxide; Asp, aspartate; Asn, asparagine; Glu, glutamate; Gly, glycine; ROS, reactive oxygen species; GSH, glutathione; GSSG, glutathione disulfide; TXN, thioredoxin; NADP+: nicotinamide adenine dinucleotide phosphate, oxidized; NADPH: nicotinamide adenine dinucleotide phosphate, reduced. Enzymes: G6PD, glucose-6-phosphate dehydrogenase; PGD, phosphogluconate dehydrogenase; TALDO1, transaldolase 1; TKT, transketolase; PPAT, phosphoribosyl pyrophosphate amidotransferase; MTHFD2, methylenetetrahydrofolate dehydrogenase 2; PHGDH, 3-phosphoglycerate dehydrogenase; PSAT1, phosphoserine aminotransferase 1; SHMT1/2, serine hydroxymethyltransferase; FECH, ferrochelatase; HMOX1, heme oxygenase 1; BLVRB1, biliverdin reductase B 1; ME1, malic enzyme 1; IDH1, isocitrate dehydrogenase1; FAS, fatty acid synthase; GLS, glutaminase; ASNS, asparagine synthetase; TXNRD1, thioredoxin reductase 1; GSR, glutathione reductase; GCLC, glutamate-cysteine-ligase catalytic subunit; GCLM, glutamate-cysteine ligase modifier subunit; GPX4, glutathione peroxidase 4. Other: SLC7A11/xCT: cystine glutamate antiporter.